Literature DB >> 17988275

Risk factors for chronic constipation and a possible role of analgesics.

J Y Chang1, G Richard Locke, C D Schleck, A R Zinsmeister, N J Talley.   

Abstract

Constipation has an estimated prevalence of 15% in the general population. However, the etiopathogenesis of this condition remains relatively obscure. This study sought to identify potentially novel risk factors for chronic constipation. A valid self-report questionnaire was mailed to an age- and gender-stratified random sample of Olmsted County, Minnesota residents aged 30-64 years. A logistic regression model that adjusted for age, gender and somatic symptom score (SSC) was used to identify factors associated with chronic constipation. People reporting symptoms of irritable bowel syndrome (IBS) were excluded. Of the 892 eligible subjects, 653 (73%) returned the survey. Among the 523 subjects not reporting IBS symptoms, chronic constipation was reported by 93 (18%) of the respondents. Chronic constipation was significantly associated with use of acetaminophen [>or=7 tablets per week, OR = 2.7 (1.1-6.6)]; aspirin [OR = 1.7 (1.0-2.7)]; non-steroidal anti-inflammatory drugs [OR = 1.8 (1.1-3.0)]; and SSC. No association was detected for age, gender, body mass index, marital status, smoking, alcohol, coffee, education level, food allergy, exposure to pets, stress, emotional support, or water supply. Chronic constipation is associated with use of acetaminophen, aspirin and non-steroidal anti-inflammatory drugs. The explanation of these associations requires further investigation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17988275     DOI: 10.1111/j.1365-2982.2007.00974.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  27 in total

1.  Suppression of contractile activity in the small intestine by indomethacin and omeprazole.

Authors:  Lenard M Lichtenberger; Deepa Bhattarai; Tri M Phan; Elizabeth J Dial; Karen Uray
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-02-26       Impact factor: 4.052

2.  An unusual systemic reaction associated with topical salicylic acid in a paediatric patient.

Authors:  Anna Loraschi; Rosaria Marelli; Francesca Crema; Sergio Lecchini; Marco Cosentino
Journal:  Br J Clin Pharmacol       Date:  2008-03-13       Impact factor: 4.335

3.  Green-lipped mussel (Perna canaliculus) extract efficacy in knee osteoarthritis and improvement in gastrointestinal dysfunction: a pilot study.

Authors:  Samantha Coulson; Phillip Vecchio; Helen Gramotnev; Luis Vitetta
Journal:  Inflammopharmacology       Date:  2012-02-26       Impact factor: 4.473

4.  Constipation and risk of cardiovascular disease among postmenopausal women.

Authors:  Elena Salmoirago-Blotcher; Sybil Crawford; Elizabeth Jackson; Judith Ockene; Ira Ockene
Journal:  Am J Med       Date:  2011-06-12       Impact factor: 4.965

5.  Irritable bowel syndrome and chronic pelvic pain: a population-based study.

Authors:  Rok Seon Choung; Linda M Herrick; Giles Richard Locke; Alan R Zinsmeister; Nicholas J Talley
Journal:  J Clin Gastroenterol       Date:  2010 Nov-Dec       Impact factor: 3.062

6.  Lack of familial aggregation in chronic constipation excluding irritable bowel syndrome: a population-based study.

Authors:  Joseph Y Chang; G Richard Locke; Cathy D Schleck; Alan R Zinsmeister; Nicholas J Talley
Journal:  Dig Dis Sci       Date:  2014-12-23       Impact factor: 3.199

Review 7.  Update on the Management of Chronic Constipation.

Authors:  Jenna Koliani-Pace; Brian E Lacy
Journal:  Curr Treat Options Gastroenterol       Date:  2017-03

8.  Direct and indirect medical costs of functional constipation: a population-based study.

Authors:  Hamid Mohaghegh Shalmani; Hamid Soori; Babak Khoshkrood Mansoori; Mohsen Vahedi; Bijan Moghimi-Dehkordi; Mohammad Amin Pourhoseingholi; Mohsen Norouzinia; Mohammad Reza Zali
Journal:  Int J Colorectal Dis       Date:  2010-10-19       Impact factor: 2.571

9.  Risk factors for chronic diarrhoea in the community in the absence of irritable bowel syndrome.

Authors:  J Y Chang; G Richard Locke; C D Schleck; A R Zinsmeister; N J Talley
Journal:  Neurogastroenterol Motil       Date:  2009-05-21       Impact factor: 3.598

Review 10.  Management of Opioid-Induced Constipation and Bowel Dysfunction: Expert Opinion of an Italian Multidisciplinary Panel.

Authors:  Roberto De Giorgio; Furio Massimino Zucco; Giuseppe Chiarioni; Sebastiano Mercadante; Enrico Stefano Corazziari; Augusto Caraceni; Patrizio Odetti; Raffaele Giusti; Franco Marinangeli; Carmine Pinto
Journal:  Adv Ther       Date:  2021-06-04       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.